Sensus Healthcare Inc [SRTS] stock is trading at $5.3, up 6.85%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SRTS shares have gain 11.34% over the last week, with a monthly amount glided 39.47%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sensus Healthcare Inc [NASDAQ: SRTS] stock has seen the most recent analyst activity on January 31, 2025, when Lake Street initiated its Buy rating and assigned the stock a price target of $18. Previously, Maxim Group reaffirmed its Buy rating on November 15, 2024, and elevated its price target to $14. On February 26, 2021, upgrade upgraded it’s rating to Outperform. Northland Capital downgraded its rating to a Market Perform. Alliance Global Partners upgraded its rating to a Buy and raised its price target to $4.25 on August 10, 2020. Alliance Global Partners upgraded its rating to Buy for this stock on February 14, 2020, but kept the price target unchanged to $6. In a note dated November 07, 2019, B. Riley FBR downgraded an Neutral rating on this stock and revised its target price from $14 to $5.50.
Sensus Healthcare Inc [SRTS] stock has fluctuated between $3.03 and $9.08 over the past year. Currently, Wall Street analysts expect the stock to reach $10 within the next 12 months. Sensus Healthcare Inc [NASDAQ: SRTS] shares were valued at $5.3 at the most recent close of the market. An investor can expect a potential return of 88.68% based on the average SRTS price forecast.
Analyzing the SRTS fundamentals
Sensus Healthcare Inc [NASDAQ:SRTS] reported sales of 35.61M for the trailing twelve months, which represents a drop of -22.12%. Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.08%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.06 and Total Capital is -0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Sensus Healthcare Inc’s Current Ratio is 7.38. Further, the Quick Ratio stands at 5.27, while the Cash Ratio is 3.59. Considering the valuation of this stock, the price to sales ratio is 2.44, the price to book ratio is 1.70.
Transactions by insiders
Recent insider trading involved Sachetta Eric, Director, that happened on Nov 21 ’25 when 7000.0 shares were purchased. Director, Sachetta Eric completed a deal on Nov 13 ’25 to buy 2500.0 shares. Meanwhile, CHIEF EXECUTIVE OFFICER Sardano Joseph C bought 25000.0 shares on Nov 18 ’25.
